Maxwellia Announces Appointment of Paresh Baldaniya as Head of Quality & Regulatory Affairs

maxwellia logo 2.png
Maxwellia pr.jpg

Maxwellia, the UK’s only dedicated expert medicines switch company, has appointed Paresh Baldaniya in the newly created role of Head of Quality & Regulatory Affairs. The appointment is a reflection of the company’s huge growth over the past 12 months and the timing comes as Maxwellia is poised to create a major step-change in women’s health with the launch of a much-awaited new product.

Paresh has a pharmacy background and a stellar track record, spanning over 10 years in regulatory affairs and quality expertise. Before joining Maxwellia, he worked for a number of different companies in pharmaceuticals and medical devices across Europe, the Middle East, Asia Pacific and USA markets.

Maxwellia founder and CEO, Anna Maxwell says: “Having a strong leadership team is essential to enable us to continue to build an unbeatable business. We welcome Paresh on board; he shares our vision of widening access to medicines through pharmacy and his experience and talent will further support our company as we enter a very exciting new phase of growth”.

Founded in 2013 by CEO, pharmacist and self-care visionary, Anna Maxwell, team Maxwellia are based at Alderley Park, Alderley Edge in Cheshire. For more information visit www.maxwellia.com or email us at info@maxwellia.com.

Daniella McCarron